Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrice Couzigou

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Gastroenterologie Clinique Et Biologique|April 9, 2002
Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipientsEvelyne Schvoerer, Imed Kabissa, Emmanuelle Cotto, et al.
Journal of Hepatology|October 13, 2006
Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years)Victor de Lédinghen, Pascale Trimoulet, Paul-Régis Mannant, et al.
Journal of Hepatology|June 5, 2002
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon aloneVictor de Lédinghen, Pascale Trimoulet, Maria Winnock, et al.
Endoscopy|March 3, 2015
Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective studySylvie Sacher-Huvelin, Paul Calès, Christophe Bureau, et al.
Journal of Hepatology|May 2, 2002
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis CVictor de Lédinghen, Pascale Trimoulet, Maria Winnock, et al.
World Journal of Gastroenterology|December 5, 2006
Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective studyLaurent Castéra, Anne Pedeboscq, Marcia Rocha, et al.
Gastroenterologie Clinique Et Biologique|January 8, 2008
Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004Pascale Trimoulet, Mathieu Boutonnet, Maria Winnock, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
ESMO Open|November 7, 2017
Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinomaPhilippe Merle, Philippe Camus, Armand Abergel, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Gastroenterologie Clinique Et Biologique|April 9, 2002
Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipientsEvelyne Schvoerer, Imed Kabissa, Emmanuelle Cotto, et al.
Journal of Hepatology|October 13, 2006
Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years)Victor de Lédinghen, Pascale Trimoulet, Paul-Régis Mannant, et al.
Journal of Hepatology|June 5, 2002
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon aloneVictor de Lédinghen, Pascale Trimoulet, Maria Winnock, et al.
Endoscopy|March 3, 2015
Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective studySylvie Sacher-Huvelin, Paul Calès, Christophe Bureau, et al.
Journal of Hepatology|May 2, 2002
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis CVictor de Lédinghen, Pascale Trimoulet, Maria Winnock, et al.
World Journal of Gastroenterology|December 5, 2006
Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective studyLaurent Castéra, Anne Pedeboscq, Marcia Rocha, et al.
Gastroenterologie Clinique Et Biologique|January 8, 2008
Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004Pascale Trimoulet, Mathieu Boutonnet, Maria Winnock, et al.
Gastroenterology|March 29, 2011
High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)Stéphane Chevaliez, Christophe Hézode, Alexandre Soulier, et al.
ESMO Open|November 7, 2017
Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinomaPhilippe Merle, Philippe Camus, Armand Abergel, et al.
Pageof 6